Page 79 - Relevant Persons News Today

By Notice of Repurchase Offer dated March 25, 2021 (the Notice), Santhera Pharmaceuticals Holding AG announced an offer to exchange its outstanding CHF 60 million 5% Convertible Bonds due 2022 (the 2017/22 Bonds) on the terms set out in the Notice (the Exchange Offer). The Exchange Offer was accepted by bondholders with respect to 2017/22 Bonds with an aggregate principal amount of CHF 44,845,000, corresponding to 74.7% of all 2017/22 Bonds in circulation. S ettlement Santhera has decide...

  THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR FORM ANY PART OF AN OFFER TO SELL OR ISSUE, OR A SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY SECURITIES IN THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA (COLLECTIVELY, THE "UNITED STATES")), AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH OFFER OR SOLICIT...

DGAP-Ad-hoc: Obotech Acquisition SE / Key word(s): IPO Obotech Acquisition SE launches bookbuilding for up to EUR 200 million private placement and listing on Frankfurt Stock Exchange 29-Apr-2021

Nachricht vom 29.04.2021 | 14:54 OboTech Acquisition SE launches bookbuilding for up to EUR 200 million private placement and listing on the Frankfurt Stock Exchange DGAP-News: Obotech Acquisition SE / Key word(s): IPO 29.04.2021 / 14:54 The issuer is solely responsible for the content of this announcement. NOT FOR DISTRIBUTION, PUBLICATION OR FORWARDING, EITHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH ...

DGAP-News: Obotech Acquisition SE: IPO DGAP-News: Obotech Acquisition SE / Key word(s): IPO OboTech Acquisition SE launches bookbuilding for up to EUR 200 million private placement and listing on the Frankfurt Stock Exchange 29.04.2021 / 14:54 The issuer is solely responsible for the content of this announcement. NOT FOR DISTRIBUTION, PUBLICATION OR FORWARDING, EITHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SU...

DGAP-Adhoc: Obotech Acquisition SE: Obotech Acquisition launches bookbuilding for up to EUR 200 million private placement and listing on Frankfurt Stock Exchange Important Notice This publication may not be published, distributed or transmitted in the United States, Canada, Australia or Japan. This publication does not constitute an offer of securities for sale or a solicitation of an offer to purchase securities (the "Securities") of OboTech Acquisition SE (the "Company") in the United States...

DISCLAIMER This publication may not be published, distributed or transmitted in the United States, Canada, Australia, South Africa or Japan. This publication does not constitute or forms part of any offer of securities for sale or a solicitation of an offer to purchase securities (the "Securities") or any of the assets, business or undertakings of 468 SPAC I SE (the "Company") in the United States, Australia, Canada, South Africa, Japan or any other jurisdiction in which such offer or solicitat...

Proposed Placing of New Ordinary Shares JTC, the global provider of fund, corporate and private client services, announces its intention to conduct a non pre-emptive placing of new ordinary shares (the "Placing Shares") of 1p each in the capital of the Company (the "Placing") to raise gross proceeds of up to c. £65m, representing approximately 9.0 per cent. of the current issued share capital of the Company. The total number of Placing Shares will not exceed 10.0 per cent. of the c...

DGAP-News: 468 SPAC I SE / Key word(s): IPO 468 SPAC I SE: completes €300 million private placement 29.04.2021 / 15:30 The issuer is solely responsible for

Search jobs 29-Apr-2021 APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share DGAP-News: APONTIS PHARMA AG / Key word(s): IPO 29.04.2021 / 08:30 The issuer is solely responsible for the content of this announcement. NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE ...